The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List
ChartZero.com
ChartZero
Biogen Idec Inc (BIIB)

Biogen Idec is a biotechnology company focused on discovering, developing, manufacturing and marketing therapies for the treatment of multiple sclerosis (MS) and other autoimmune disorders, neurodegenerative diseases and hemophilia. Co.'s products include: AVONEX (interferon beta-1a), indicated for MS; TYSABRI (natalizumab), indicated for MS and Crohn's disease; TECFIDERA (dimethyl fumarate), indicated for MS; FAMPYRA (prolonged-release fampridine tablets), indicated for MS (walking ability); FUMADERM (fumaric acid esters), indicated for psoriasis; and RITUXAN (rituximab), indicated for Non-Hodgkin's lymphoma, rheumatoid arthritis, lymphocytic leukemia, and ANCA-associated vasculitis.

Recommended for you: 25 S.A.F.E. Dividend Stocks
Company Name:  Biogen Idec Inc
Website:  www.biogenidec.com
Sector:  Biotechnology
Number of ETFs Holding BIIB:  80
Total Market Value Held by ETFs:  $4.21B
Total Market Capitalization:  $81.08B
% of Market Cap. Held by ETFs:  5.19%
August 30, 2014    6:10 AM Eastern


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Quotes delayed 20 minutes



Buy (3.35 out of 4)
67th percentile
(ranked higher than approx. 67% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Biogen Idec Inc (BIIB) Page | The Online Investor | www.TheOnlineInvestor.com | Copyright © 1998 - 2014, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.